Tuesday, December 2, 2025

CMMNJ Meeting Agenda for December 9, 2025

 


CMMNJ Monthly Zoom Meeting Agenda for December 9, 2025 at 7 pm

Join Zoom Meeting:
https://us02web.zoom.us/j/84923971546?pwd=A5gWBPn4Jbcq1kgCNcnJPBa500vH6o.1

Meeting ID: 849 2397 1546

Passcode: 424112

One tap mobile: +1 (309) 205-3325, 84923971546#, 424112# US

Join instructions: 

https://us02web.zoom.us/meetings/84923971546/invitations?signature=XcnTgmqVNE5rgFkTHZmLuT4mskRyFp3ir1hYMWFHDAo 

This is a free, open, non-judgmental space for individuals to express their opinions and thoughts on current events and issues on medical marijuana. 

Agenda: New Jersey Issues:

With Mikie Sherrill as NJ’s Governor-elect, there’s now a decidedly clearer path to advancing a medical and adult use home grow option. Sherrill also advocated to include active duty military service members in psychedelic studies. NORML gave Sherrill an “A” grade in its voter guide. The Governor-elect invites direct public participation through a statewide Transition Survey. New Jersey residents are encouraged to share their ideas and priorities for the next administration. 

CMMNJ Position on NJ Bill S4847: Makes various changes to CRC and to the cannabis marketplace; Testimony to the Senate Judiciary Committee. The bill passed out of committee with minor amendments. Referred to Senate Budget and Appropriations Committee. 

Testimony in support of S2392/A913: Authorizes medical cannabis for treatment of sickle cell anemia. The bill passed out of the Senate Health Committee and was referred to the Senate Budget and Appropriations Committee. 

The "Psilocybin Behavioral Health Access and Services Act," A3852/S2283, passed out of committee on 11/24/25. It establishes Psilocybin Behavioral Health Access and Therapy Pilot Program and appropriates $6 million. It will charge the Department of Health with licensing and regulating the manufacture, testing, transport, delivery, sale and purchase of psilocybin. There would be five license types: manufacturer, service center operator, testing laboratory, facilitator and psilocybin worker. Referred to Assembly Appropriations Committee.

The PhilaDelic Conference, 11/22/25, was an initiative of the Penn Psychedelics Collaborative at the University of Pennsylvania. Full agenda. CMMNJ speakers in conference recording. 

Even though NJ legalized marijuana, it is still federally illegal to mailFlower, Edibles, Vapes, Oils, Medical marijuana. One exception: Hemp and CBD products containing less than 0.3% THC are allowed, but they must meet federal rules. When in doubt, don’t mail it.

NJ DUI Lawyer Issues Guidance On Marijuana DUI Rights And Defenses: prosecutors must prove actual impairment. That relies on observational proof and opinion testimony rather than a single objective number, which in turn creates multiple litigation touchpoints for challenging probable cause, arrest procedures, and admissibility of evidence. 

Sign the Petition: Legalize Medical Home Cultivation for NJ Patients Now!

S4779: transfers cannabis regulations from the CRC to a new Division of State Cannabis Oversight, Regulation, and Enforcement (SCORE) in the Dept. of Law and Public Safety, to bring enforcement actions against unlicensed cannabis businesses. 

NJ Senator Scutari’s bill S4154, “Establishes crime of selling or purchasing marijuana from unlicensed businesses." Sign NORML's S4154 action alert

Let Advanced Practice Nurses Recommend Medical Cannabis: NORML petition 

The Cannabis Regulatory Commission (CRC):

Next meeting: December 17, 2025. Register to speak here by 12/15/25 at 5 p.m. Submit comments in writing by 12/18/25 at 5 p.m.

Watch on Zoom or on YouTube

Full recordings, slides of public meetings, and upcoming meeting dates are available on the CRC public meeting page.

CRC: Your guide to cannabis consumption areas

"Tips for SMART Gatherings This Holiday Season" Be Safe. Be Mindful. Be Aware. Be Responsible. Be Thoughtful. Be S.M.A.R.T. this holiday season. 

Medicinal Cannabis Program Participation (as of 11/15/2025)

  • Total patients: 52,819
  • Caregivers: 3,425
  • Doctors: 1,556 

Federal and International Drug Policy Reform:

Accelerate Cannabis Mid-Atlantic Summit Discusses Minority Ownership; it focused on the East Coast’s emerging cannabis markets across PA, NJ, MD, DE, NY, and VA, and how all of these states should be learning from each other and adopting laws that work and recognizing those that don’t.

The Medical Cannabis Patient’s Guide for U.S. Travel is Updated for Another Holiday Season

Congress Bans Most Hemp Products, Leaving Industry Unsettled and Uncertain;  the US Hemp Roundtable declared "it ain't over." Noting that thanks to Sen. Paul, the industry has 365 days before the ban goes into effect, the group said it was confident it can find "a path forward" in the interim.

No Need to Ban Hemp Products When You Can Regulate Them

Federal Appeals Court Deems Gun Ban For Marijuana Consumers Unconstitutional; a coalition of gun rights organizations recently urged the Supreme Court to expand its examination of the constitutionality of the federal firearm ban for cannabis consumers

Supreme Court To Discuss Marijuana Companies’ Case Seeking To Overturn Federal Prohibition; justices set December 12 when court will discuss whether to formally take up the case or not. The court is being asked to settle the question of whether imposing federal marijuana criminalization within states that have enacted their own legalization laws violates the Commerce Clause of the U.S. Constitution.

No Upcoming Events are scheduled.

CMMNJ’s ongoing goals:

Insurance bills: Press release: NJSNA supports insurance for medicinal cannabis

·        S1944: Costs of medical cannabis to be reimbursed by Catastrophic Illness in Children Relief Fund, PAAD, Senior Gold and VCCO.

·        S1943/A4371: Requires workers’ compensation, PIP, and health insurance coverage.

·        A898/ S2828: Subsidize medical cannabis in Medicaid or NJ Family Care.

Home cultivation bills: Website: https://www.letpatientsgrownj.com/

Petition: End the Blockade on NJ Senate bill S1393; it has bipartisan co-sponsors, but no committee hearing scheduled yet. Sign NORML’s S1393 Action Alert.

·        S1393/A846: Authorizes home cultivation of medical cannabis.

·        S1985/A3867: Legalizes six plants for personal use and 10 plants for medical

Hospital and Institutional Access:

NJ patients in hospitals, nursing homes, state institutions, group homes and hospice need access to medical cannabis. Patient outcomes would improve, and health care costs would be reduced with access to medical cannabis.

Treasury report: $8,662.

Fundraising ideas are always welcome. CMMNJ has thousands of hemp wristbands. Can your organization use them? See the photo below.

Make a tax-deductible donation via PayPal to info@cmmnj.org, or send a check to: CMMNJ, 219 Woodside Ave., Trenton, NJ 08618

Or scan:

Image

More info: 

Ken Wolski, RN, MPA (609) 394-2137 ohamkrw@aol.com 

Facebook: Friends of CMMNJ: https://www.facebook.com/groups/62462971150/

Twitter/X: @CMM_NJ

CMMNJ bloghttps://cmmnj.blogspot.com/

CMMNJ website: https://cmmnj.org/

CMMNJ Awards:

2021: NJ Governor's Jefferson Award in the Volunteer Group category;

2023: NJ State Governor's Volunteerism Award in the Dr. Martin Luther King Jr. Champion for Justice Category "for extraordinary service to your community;"

2023: Ken Wolski won a Lifetime Achievement award;

2023: NJ Senate and Assembly Joint Legislative Resolution affirmed CMMNJ's importance as a "catalyst for the legalization of both medical and recreational marijuana in the State" and paid “tribute to all who have contributed to its success and renown.”

CMMNJ, a 501(c)(3) public charity, is a non-profit educational organization.

CMMNJ Position on NJ Senate Bill S4847

 


Testimony to the Senate Judiciary Committee
State House Annex, Trenton, NJ
Monday, December 1, 2025
CMMNJ Position on NJ Senate Bill S4847

 

Overall Position:


CMMNJ opposes S4847 as currently written. The bill expands enforcement and political influence without addressing core medical patient needs: affordability, transparency, and the right to safely access or grow one’s own medicine.


1. Enforcement Without Patient Protections – Oppose

  •          Directs State Police to identify, investigate, and prosecute “unlicensed” cannabis activity.
  •          Risks harming legacy caregivers and low-income patients who rely on non-corporate access.
  •          NJ still bans home cultivation, leaving patients criminalized.

2. Ethics Loopholes & Conflicts of Interest – Oppose

  •          Allows State employees and families to work for or invest in cannabis companies.
  •          Undermines regulatory trust and risks capture.

3. Reduced Transparency & Politicization of the CRC – Oppose

  •          Permits commissioners to fundraise, campaign, meet privately with applicants.
  •          Weakens CRC Chair and politicizes regulation.

4. Corporate Expansion Without Patient Benefit – Concern

  •          Allows dispensaries to convert to adult-use without municipal approval.
  •          No affordability guarantees or medical protections.

5. No Home Cultivation – Strong Opposition

  •          NJ is the only Northeastern legal-cannabis state with no home grow.
  •          Enforcement without home grow criminalizes illness.

Recommended Amendments:

1) Legal home cultivation (6–12 plants).

2) Strong ethics safeguards.

3) Maintain CRC transparency and independence.

4) Patient affordability protections.

5) Non-criminal caregiver/cooperative pathways.

 

Summary Statement:

S4847 prioritizes enforcement and corporate interests over patient welfare. CMMNJ urges

amendments to protect patients, ensure transparency, and legalize home cultivation before advancing enforcement-based reforms.

 

Mike Brennan
Board of Directors, Coalition for Medical Marijuana--New Jersey, Inc. 
https://cmmnj.org/

219 Woodside Ave., Trenton, NJ 08618  

info@cmmnj.org


Mike Brennan's Oral Testimony to the Senate Judiciary Committee

 

Good morning Chair and members of the Committee. My name is Michael Brennan. I am a disabled cancer patient and an Associate Director of the Coalition for Medical Marijuana – New Jersey. I live every day with chronic pain and spinal injury. For patients like me, cannabis is not a luxury. It is essential medicine. And because insurance does not cover it, affordability is a matter of survival.

 

I am here to express deep concern about Senate Bill S4847 and the harmful impact it will have on medical cannabis patients.

 

First, S4847 expands policing and criminal prosecution without providing any patient-centered protections. Directing the State Police to identify, investigate, and shut down unlicensed cannabis activity may sound like regulatory housekeeping, but the reality is different. A large portion of so-called “unlicensed operators” are legacy caregivers who supply low-cost or donated medicine to patients who simply cannot afford corporate dispensary prices. Criminalizing these caregivers—while still banning home cultivation—places the burden directly on the backs of the sick, the poor, and the disabled. Patients should not be collateral damage in an enforcement strategy designed without us in mind.

 

Second, S4847 opens the door to conflicts of interest within the regulatory system. Allowing state employees and their family members to work for or invest in cannabis companies—even with ethics approval—creates the appearance of regulatory capture. In a state where medical cannabis is already among the most expensive in the nation, the public must have confidence that regulatory decisions are made for patient welfare, not corporate gain.

 

Third, the bill reduces transparency and increases politicization at the Cannabis Regulatory Commission. It permits commissioners to hold local elected office, campaign, fundraise, and meet privately with industry applicants. These changes overwhelmingly benefit well-resourced corporate actors and diminish the voice of patients who rely on open public processes to be heard.

 

Finally, S4847 expands corporate dispensary power without addressing the core issue of patient access. Towns lose authority over adult-use conversions. Corporations gain new rights. But patients gain nothing—not affordability, not access, and certainly not the right to cultivate our own medicine.

 

New Jersey is the only state in the Northeast with legal cannabis and no legal home grow. Enforcement without home grow is not policy. It is punishment.

 

CMMNJ urges this Committee to amend the bill to protect patients, restore transparency, and include reasonable home cultivation for medical users. Patients deserve compassion—not criminalization. Thank you.

 

The Coalition for Medical Marijuana—New Jersey, Inc., founded in 2003, is a 501(c)(3) non-profit educational organization whose mission is to educate the public about medical marijuana/cannabis and other plant medicine.

Monday, November 17, 2025

Authorize medical cannabis for sickle cell anemia


Testimony to the Senate Health, Human Services and Senior Citizens Committee

In support of S2392/A913: Authorizes medical cannabis for treatment of sickle cell anemia.

November 13, 2025

 

The Coalition for Medical Marijuana—New Jersey, Inc. supports the addition of sickle cell anemia to the list of qualifying medical conditions for cannabis therapy in New Jersey, but the Legislature’s valuable time should not be spent on hearings for every possible condition that may be helped by cannabis.

 

A far more efficient use of the Legislature’s time would be to allow any "health care practitioner" to recommend cannabis therapy for ANY disease, symptom, or condition that the prescriber feels may be helped by medical cannabis. Leave this issue up to the Physician, the Advanced Practice Nurse, or the Physician’s Assistant to act in the best interest of the patient.

 

The state of New Jersey has already approved numerous medical conditions as qualifying for cannabis therapy. Therefore, cannabis should be allowed to be recommended “off label” for any other condition, as is the case with prescription pharmaceuticals. Once a drug is approved for use by the FDA, that drug may be used “off label” for other conditions as determined by prescribers.

 

There are literally thousands of diseases, symptoms and medical conditions that cannabis may help. Researchers believe that the Endocannabinoid System—the system in the human body that processes internal and external cannabinoids--may play a role in all diseases.

 

S2392/A913 should pass into law, but so should a more encompassing bill regarding qualifying conditions. Thank you for your attention.

 

Ken Wolski, RN, MPA
Executive Director, Coalition for Medical Marijuana--New Jersey, Inc.

219 Woodside Ave., Trenton, NJ 08618
609.394.2137
ohamkrw@aol.com

 

Attachments: Resume of Ken Wolski, RN

 

The Coalition for Medical Marijuana—New Jersey, Inc., founded in 2003, is a 501(c)(3) non-profit educational organization whose mission is to educate the public about medical marijuana/cannabis and other plant medicine.



From: senburgess@njleg.org

To: Mr. Ken Wolski

Mon, Nov 17 at 1:20 PM


Dear Mr. Wolski,


Thank you for submitting your testimony regarding S2392/A913 and for your longstanding advocacy on behalf of patients who rely on medical cannabis. I appreciate your perspective as a registered nurse and as Executive Director of the Coalition for Medical Marijuana–New Jersey, and I am grateful for the extensive experience you bring to this discussion.

 

Your testimony offers valuable insight into both the importance of adding sickle cell anemia as a qualifying condition and the broader question of how New Jersey’s medical cannabis program can best serve patients. The points you raised about practitioner discretion, off-label therapeutic use, and efficiency in the legislative process are important considerations as we continue to evaluate this bill and the overall structure of the program.

 

As the Senate reviews S2392 and other related legislation, I will keep your comments and recommendations in mind. Hearing directly from healthcare professionals, advocates, and community stakeholders is essential in shaping policies that are compassionate, patient-centered, and grounded in real-world experience.

 

Thank you again for taking the time to provide your testimony and for your continued commitment to improving healthcare access for New Jersey residents. Please stay in contact with my office as this legislation moves forward.

 

Sincerely,

Quincy Bates


Sincerely,

Renee C. Burgess

Senator

Tuesday, November 4, 2025

CMMNJ Meeting Agenda for November 11, 2025

 


CMMNJ Monthly Zoom Meeting Agenda for November 11, 2025 at 7 pm

Join Zoom Meeting:
https://us02web.zoom.us/j/85928841048?pwd=ZArHR7wisYBNCDGREXa5W1dtQ4MuWq.1

Meeting ID: 859 2884 1048
Passcode: 952004

One tap mobile

+1 (301) 715-8592, 85928841048#,*952004# US (Washington DC)

+1 (305) 224-1968, 85928841048#,*952004# US

Join instructions

https://us02web.zoom.us/meetings/85928841048/invitations?signature=i8D_WWYlNZ73qXTtN66wnRn6qcK87B8oeIZECcAZKWc

 This is a free, open, non-judgmental space for individuals to express their opinions and thoughts on current events and issues on medical marijuana.

Agenda: New Jersey Issues:

How will NJ’s next Governor deal with drug policy reform issues? Continuing cannabis reform, access to psychedelics, and pursuit of failed War on Drugs?

CannaCoverage: Reasons to Offer Medical Cannabis as an Employee Benefit; NABIP: National Association of Benefits and Insurance Professionals programs. 

S4779: transfers cannabis regulations from the CRC to a new Division of State Cannabis Oversight, Regulation, and Enforcement (SCORE) in the Dept. of Law and Public Safety, to bring enforcement actions against unlicensed cannabis businesses. 

CMMNJ tabled at Community Fest 2025 at The College of New Jersey.

Sign the Petition: Legalize Medical Home Cultivation for NJ Patients Now!

NJ Senator Scutari’s bill S4154, “Establishes crime of selling or purchasing marijuana from unlicensed businesses." Sign NORML's S4154 action alert

Let Advanced Practice Nurses Recommend Medical Cannabis: NORML petition

 The Cannabis Regulatory Commission (CRC):

Next meeting: December 11, 2025. Register to speak here by 12/9/25 at 5 p.m. Submit comments in writing by 12/12/25 at 5 p.m.

Watch on Zoom or on YouTube

Full recordings, slides of public meetings, and upcoming meeting dates are available on the CRC public meeting page.

CRC: Your guide to cannabis consumption areas

Medicinal Cannabis Program Participation (as of 10/15/2025)

  • Total patients: 54,924
  • Caregivers: 3,505
  • Doctors: 1,552

 Federal and International Drug Policy Reform:

ASA: Why Home Cultivation Matters for Patients and Federal Policy Advisory Group summary (PowerPoint). More about the Federal Government Shutdown. ASA's New Action Group: United for National Medical Cannabis.

Ireland’s Vera Twomey: Medicinal cannabis must be administered by staff in healthcare institutions and become part of the patient's healthcare record.

DEA Promotes Ad Blaming Marijuana Laced With Fentanyl For OD Deaths

Federal Study: Access To Legal Marijuana Shops Leads To Reduced Heavy Alcohol Use

Groundbreaking Mushroom Study Delivers New Hope For Epilepsy

Society of Cannabis Clinicians (SCC) 3rd Annual Medical Cannabis Conference,

Metropolitan State University of Denver, October 24– October 25.

 Upcoming events:

PhilaDelic, UPENN psychedelic conference, Jordan Medical Education Center, 3400 Civic Center Blvd., Philadelphia, PA 19104, 11/22/25, 9-6 pm. Free virtual tickets: 

http://www.eventbrite.com/e/1486489402819/?discount=GaetanoVirtual

This will be an outstanding event discussing research and roadmaps for psychedelics and medical cannabis.

Gaetano “Guy” Lardieri

973.344.1221(Office)

201.259.9164 (Cell)


NJ League of Municipalities, Annual Conference, Atlantic City, 11/18-20

CMMNJ’s ongoing goals:

Insurance bills: Press release: NJSNA supports insurance for medicinal cannabis

·      S1944Costs of medical cannabis to be reimbursed by Catastrophic Illness in Children Relief Fund, PAAD, Senior Gold and VCCO.

·        S1943/A4371: Requires workers’ compensation, PIP, and health insurance coverage.

·        A898/ S2828: Subsidize medical cannabis in Medicaid or NJ Family Care.


Home cultivation bills: Website: https://www.letpatientsgrownj.com/

·        S1393/A846: Authorizes home cultivation of medical cannabis.

·        S1985/A3867: Legalizes six plants for personal use and 10 plants for medical

Petition: End the Blockade on NJ Senate bill S1393no committee hearing scheduled yet. Sign NORML’s S1393 Action Alert.


Hospital and Institutional Access:

NJ patients in hospitals, nursing homes, state institutions, group homes and hospice need access to medical cannabis. Patient outcomes would improve, and health care costs would be reduced with access to medical cannabis. 

In 2023 CMMNJ endorsed psychedelic research and the safe use of psychedelics.  A3852/S2283 "Psilocybin Behavioral Health Access and Services Act."

2025 Psychedelic Community Survey, a research project for the psychedelic community, by the psychedelic community.

Treasury report: $8,888.

Fundraising ideas are always welcome. CMMNJ has thousands of hemp wristbands. Can your organization use them? See the photo below.

Make a tax-deductible donation via PayPal to info@cmmnj.org, or send a check to: CMMNJ, 219 Woodside Ave., Trenton, NJ 08618

Or scan:

Image

More info: 

Ken Wolski, RN, MPA (609) 394-2137 ohamkrw@aol.com 

Facebook: Friends of CMMNJ: https://www.facebook.com/groups/62462971150/

Twitter/X: @CMM_NJ

CMMNJ bloghttps://cmmnj.blogspot.com/

CMMNJ website: https://cmmnj.org/

CMMNJ Awards:

2021: NJ Governor's Jefferson Award in the Volunteer Group category;

2023: NJ State Governor's Volunteerism Award in the Dr. Martin Luther King Jr. Champion for Justice Category "for extraordinary service to your community;"

2023: Ken Wolski won a Lifetime Achievement award;

2023: NJ Senate and Assembly Joint Legislative Resolution affirmed CMMNJ's importance as a "catalyst for the legalization of both medical and recreational marijuana in the State" and paid “tribute to all who have contributed to its success and renown.”

CMMNJ, a 501(c)(3) public charity, is a non-profit educational organization.